Deals
One British Company Saw 70% of Its Value Vanish This Week
- Options include equity issue, debt swap and asset sales
- Balance sheet concerns trump strategy, says Cenkos analyst
This article is for subscribers only.
In 2014, U.K. builder Carillion Plc was riding high: it had just won a $434 million contract to build the Royal Liverpool Hospital and was attempting to snap up its struggling rival Balfour Beatty Plc for about $2.6 billion. Three years later, and the former Tarmac business is on life support.
Carillion has lost 70 percent of its market value this week after flagging 845 million pounds ($1.09 billion) in surprise contract provisions. In an emergency move, it installed non-executive director Keith Cochrane as interim chief executive, and called in KPMG to help review its books and balance sheet, described by Liberum analyst Joe Brent as “a mess.”